Ars Investment Partners, LLC Ascendis Pharma A/S Transaction History
Ars Investment Partners, LLC
- $1.05 Billion
- Q2 2025
A detailed history of Ars Investment Partners, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ars Investment Partners, LLC holds 209,930 shares of ASND stock, worth $41.1 Million. This represents 3.45% of its overall portfolio holdings.
Number of Shares
209,930
Previous 265,164
20.83%
Holding current value
$41.1 Million
Previous $41.3 Million
12.33%
% of portfolio
3.45%
Previous 4.55%
Shares
23 transactions
Others Institutions Holding ASND
# of Institutions
276Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$975 Million15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$867 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$833 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...